Feature Channels: Vision

• share
• favorite_border

Variety of health back to school pitches from the experts at Hackensack Meridian Children's Health

• share
• favorite_border

• share
• favorite_border

The Noelin family of secreted proteins bind to the external portion of AMPA glutamate receptors and stabilize them on the neuronal cellular membrane, a process necessary for transmission of full-strength signals between neurons, according to a study in mice from the National Eye Institute (NEI) and the University of Freiberg, Germany.

• share
• favorite_border

New research shows that popular brain signatures of prediction error are only generated in the presence of attention to the visual stimuli, despite early brain encoding of those stimuli.

• share
• favorite_border

A brief roundup of news and story ideas from the experts at UCLA Health.

• share
• favorite_border

• share
• favorite_border

The T. Boone Pickens Foundation, established by the late, Texan innovative energy leader and philanthropist, is donating $20 million to the Wilmer Eye Institute, Johns Hopkins Medicine.

• share
• favorite_border

The American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery (ASCRS), and the Georgia Society of Ophthalmology applaud Humana for rolling back its prior authorization requirement for cataract surgery for Medicare Advantage beneficiaries in Georgia.

• share
• favorite_border

A new study lends further weight to the idea that vision problems and dementia are linked. In a sample of nearly 3,000 older adults who took vision tests and cognitive tests during home visits, the risk of dementia was much higher among those with eyesight problems – including those who weren’t able to see well even when they were wearing their usual eyeglasses or contact lenses.

• share
• favorite_border

The National Cancer Institute of the National Institutes of Health (NIH) has awarded Dr. Berry $2.8 million to lead the first prospective international retinoblastoma liquid biopsy study to date.

• share
• favorite_border

Microwaving hard-boiled eggs is one of the latest TikTok trends that can harm your eyes

• share
• favorite_border

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

• share
• favorite_border

New Alzheimer’s research from UVA Health suggests that enhanced light sensitivity may contribute to “sundowning” – the worsening of symptoms late in the day – and spur sleep disruptions thought to contribute to the disease’s progression.

• share
• favorite_border

Patricia Ann D’Amore, PhD, MBA, has been selected as the 2024 RPB David F. Weeks Award for Outstanding Vision Research (Weeks Award). Dr. D’Amore will receive her award and deliver a presentation during the AUPO 2024 Annual Meeting in Austin, Texas in February.

• share
• favorite_border

Designed by researchers at NYU Tandon School of Engineering and NYU Grossman School of Medicine, Commute Booster routes public-transportation users through the “middle mile” – the part of a journey inside subway stations or other similar transit hubs – in addition to the “first” and “last” miles that bring travelers to and from those hubs.

• share
• favorite_border

The recently released 2022 impact factor scores reveal that the research journals Ophthalmology, Ophthalmology Retina and Ophthalmology Glaucoma are ranked highly in the field.

• share
• favorite_border

An international research team from Queen Mary University of London, UK and the Rovereto Civic Museum Foundation, Italy has made a groundbreaking discovery regarding reptiles and their ability to match visual and auditory information.

• share
• favorite_border

Investigators from Cedars-Sinai have provided new understanding of how diabetes delays wound healing in the eye, identifying for the first time two related disease-associated changes to the cornea.

• share
• favorite_border

Prof Sei-ichi Tsujimura of the Nagoya City University and Prof Su-Ling Yeh of National Taiwan University and Kagoshima University, have discovered that our visual acuity (contrast sensitivity) can be improved by using a light with a special spectrum that can selectively stimulate melanopsin cells in the retina.

• share
• favorite_border

Improving diagnosis in health care is a moral, professional and public health imperative, according to the U.S. National Academy of Medicine.

• share
• favorite_border

• share
• favorite_border

A new partnership between HF Healthcare Services, a wholly-owned subsidiary of Humanity First USA, and the distinguished Loyola Medicine, a member of Trinity Health, will develop a state-of-the-art Ophthalmology Department at Nasir Hospital in Guatemala, which will serve thousands of patients.

• share
• favorite_border

UT Southwestern Medical Center researchers have identified a gene called Lipe that appears to be pivotal to retinal health, with mutations spurring immune activation and retinal degeneration. This is important because the retina is responsible for detecting the light that is transformed into vision. The findings, published in Communications Biology, provide clues about the mechanisms behind a variety of disorders affecting the retina, including macular degeneration and diabetic retinopathy.

• share
• favorite_border

In Physics of Fluids, Vega et al. researched human tears at the micron level to reveal new ways of customizing artificial tears to address individual symptoms of dry eye disease. The detailed insights they gained about the composition and behavior of tears could also apply to the study of ocular pathogens as well as other biological fluids. The authors collected healthy human tears and tested 10 different formulations of artificial tears and applied microrheology methods using dynamic light scattering.

• share
• favorite_border

Glaucoma can develop for years before you experience a symptom. A Penn State Health optometrist discusses early diagnosis and how testing can make all the difference for your vision.

• share
• favorite_border

The American Academy of Ophthalmology today announced that it has established a new membership group to support the professional interests of allied health professionals and will welcome in members of the Association of Technical Personnel in Ophthalmology.

• share
• favorite_border

While Loyola Medicine does not condone unsanctioned displays, if people participate, there are a number of safety precautions that can reduce or prevent injuries.

• share
• favorite_border

Research from Ann & Robert H. Lurie Children’s Hospital of Chicago promises to spare many premature infants from undergoing invasive eye exams to detect retinopathy of prematurity (ROP), the most common cause of preventable lifelong blindness in children in the U.S.

• share
• favorite_border

American adults 65 years old and older living in warmer regions are more likely to have serious vision impairment than their peers living in cooler regions, according to a recent study published in the journal Ophthalmic Epidemiology.

• share
• favorite_border

To help people with visual impairments gain more independence, Cal State Fullerton computer engineering students developed assistive glasses, a hands-free wearable technology device. The glasses can help people with visual impairments detect and identify often-used objects — something a guide dog cannot always do.

• share
• favorite_border

Fourth of July celebrations and fireworks-related emergencies are here. Gabriela Espinoza, M.D., professor of ophthalmology at Saint Louis University School of Medicine, has eye safety tips you need to know.

• share
• favorite_border

• share
• favorite_border

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).

• share
• favorite_border

• share
• favorite_border

Having the right care close to home is critical for many families.

• share
• favorite_border

Seenu M. Hariprasad, MD, the Shui-Chin Lee Professor of Ophthalmology, will be appointed Chair of the Department of Ophthalmology and Visual Science at the University of Chicago. He has been serving as Interim Chair since 2020.

• share
• favorite_border

IIT Kanpur has licensed a pioneering technology to Reliance Life Sciences Pvt. Ltd. that has the potential to revolutionize the field of gene therapy, especially for many genetic eye diseases, making it the first time that a gene therapy related technology has been developed and transferred from an academic institution to a company in India.

• share
• favorite_border

A novel, minimally invasive surgical technique for correcting blepharoptosis – often called “droopy eyelid” – is more efficient and produces better results than the traditional method that uses sutures, according to a UT Southwestern Medical Center study. The findings, reported in the American Journal of Ophthalmology, may lead to a shift in how oculoplastic surgeons treat this common condition.

• share
• favorite_border

The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon.

• share
• favorite_border

Established in 1995, the Glaucoma Foundation's Annual Think Tank has significantly increased the number of people around the world working in the field of glaucoma. All of the speakers at this 2-day will attend in person and the conference will be live-streamed on Zoom.

• share
• favorite_border

Last month at its 2023 Annual Meeting in New Orleans, La., the Association for Research in Vision and Ophthalmology (ARVO) welcomed Patricia A. D’Amore, PhD, MBA, FARVO, as its new president for April 2023 – May 2024. A member for more than 40 years, D’Amore is a Gold Fellow of ARVO (FARVO) ― a recognition of her individual accomplishments, leadership, and contributions to the Association.

• share
• favorite_border

Donors, patients, the board of directors, and volunteers joined together to mark an important milestone in Glaucoma Research Foundation’s history of innovation and collaboration. Ruth Williams, MD, Vice-Chair of the Board of Directors, was the keynote speaker.

• share
• favorite_border

Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.